CCSI Q2 2026 Earnings Call Summary

1Key Financial Results and Metrics

Consolidated Revenue:: $91.4 million, a 4.1% increase year-over-year.

Corporate Revenue:: $60.5 million, up 9.3% year-over-year, marking the strongest growth since Q4 2022.

SoHo Revenue:: $30.9 million, down 4.7% year-over-year, but an improvement from a 9.5% decline in Q1 2026.

Adjusted EBITDA:: $48.3 million, with a margin of 52.9%, consistent with the target range of 50%-55%.

Free Cash Flow:: $25.5 million, a 25% increase from Q2 2025.

Adjusted EPS:: $1.49, a 2.1% increase year-over-year.

Net Revenue Retention Rate:: 103.1%, indicating strong customer retention and expansion.

2Strategic Updates and Business Highlights

Healthcare Strategy and Solutions Group:: Formation of a new division to enhance healthcare product offerings, led by Steve Tolle, aimed at integrating AI and interoperability into clinical workflows.

Acquisition of doc.health:: Aimed at expanding capabilities in workflow management around patient care, enhancing the Harmony platform.

Corporate Channel Growth:: Continued focus on high-value corporate revenue, with a customer base increase to approximately 67,000, reflecting a 9.4% year-over-year growth.

Public Sector Engagement:: Strong performance with the Department of Veterans Affairs (VA), which is expected to contribute over $9 million in revenue for 2026 due to a policy mandating the use of eFax solutions.

3Forward Guidance and Outlook

Full Year 2026 Guidance:: Revenue expected between $350 million and $364 million, with adjusted EBITDA between $182 million and $193 million.

Q3 2026 Guidance:: Revenue projected between $89.2 million and $93.2 million, and adjusted EBITDA between $45 million and $48 million.

Free Cash Flow Expectation:: Anticipated to align with 2025 levels at approximately $106 million.

4Bad News, Challenges, or Points of Concern

SoHo Channel Management:: Revenue is being managed for cash optimization rather than subscriber growth, leading to expected volatility in subscriber metrics.

Market Conditions:: Hospitals are exhibiting slower spending and more cautious vendor selection, which may impact future sales and growth.

Hiring and Cost Management:: While hiring has ramped up, increased costs from hiring and professional fees may pressure margins in the latter half of the year.

5Notable Q&A Insights

Demand Environment:: Hospitals are more diligent in vendor selection, focusing on ROI, which CCSI is adapting to in their sales strategy.

Guidance Philosophy:: The company maintains a conservative approach to guidance, opting not to raise forecasts despite positive performance, indicating a cautious outlook amid market uncertainties.

VA ECFax Rollout:: Approximately 65%-80% of the VA rollout is complete, with expectations for further growth in public sector engagements, although the pace of government procurement remains slow. Overall, CCSI reported solid financial growth in Q2 2026, driven by corporate revenue and strategic initiatives in healthcare solutions, while navigating challenges in the SoHo channel and cautious market conditions.